Patents
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
05/2014
05/15/2014US20140134135 Methods and compositions for preserving lean body mass during weight loss
05/15/2014US20140134133 Heteroaromatic compounds as pi3 kinase modulators and methods of use
05/15/2014US20140134132 Cyclic peptides and use as medicines
05/15/2014US20140134131 Immune Regulation
05/15/2014US20140134130 Fused bicyclic oxalamide compounds for the treatment of hepatitis c
05/15/2014US20140134119 Rosacea treatments using polymetal complexes
05/15/2014US20140134113 Pharmaceutical compositions
05/15/2014DE102012015029A1 Zusammensetzungen zur Linderung von Gastrointestinaltraktstörungen oder damit assoziierter systemischer Störungen von Wiederkäuern und Cameliden Compositions for relief of gastrointestinal tract in or associated with a systemic disorder of ruminants and camelids
05/14/2014EP2730290A1 Adhesive skin patch containing serotonin receptor antagonist drug
05/14/2014EP2730281A1 Anti-obesity agent comprising high-purity epa
05/14/2014EP2730280A1 A pharmaceutical composition comprising a menthane carboxylic acid amide
05/14/2014EP2730277A2 Drug carrier and drug carrier kit for inhibiting fibrosis
05/14/2014EP2729216A1 Pharmaceutical composition for neurological disorders
05/14/2014EP2729183A1 Enhanced in vivo targeting of radiolabelled peptides with the means of enzyme inhibitors
05/14/2014EP2729147A1 Nk-1 receptor antagonists for treating corneal neovascularisation
05/14/2014CN103784976A 干扰素调节因子9(irf9)及其抑制剂在肝脏缺血疾病中的应用 Interferon regulatory factor 9 (irf9) and its inhibitors in hepatic ischemia disease
05/14/2014CN103784971A Irf3基因在动脉粥样硬化中的功能及其抑制剂的应用 Irf3 genes in atherosclerosis and their inhibitors in functional applications
05/14/2014CN103784962A 抑制神经胶质瘤生长的组合物及其应用 Inhibit the growth of glioma composition and application
05/14/2014CN103784961A Irf9在支架及内膜剥脱术后再狭窄中的功能及其抑制剂的应用 Irf9 feature stent restenosis after endarterectomy and Its Inhibitors Applications
05/14/2014CN103784960A 使用乙酰透明质酸的治疗方案 Treatment using hyaluronan
05/14/2014CN103784959A 一种治疗帕金森病的药物组合物 A treatment for Parkinson's disease, a pharmaceutical composition
05/14/2014CN103784958A 一种治疗帕金森综合症的药物组合物 A treatment for Parkinson's disease pharmaceutical composition
05/14/2014CN103784957A 一种治疗帕金森综合症的药物组合物 A treatment for Parkinson's disease pharmaceutical composition
05/14/2014CN103784956A 一种药物组合物作为制备治疗帕金森综合症的药物的应用 A pharmaceutical composition for the treatment of Parkinson's disease as an application for preparing drugs
05/14/2014CN103784473A 猪的子宫炎症治疗 Uterine inflammation treatment of pigs
05/14/2014CN103784465A 乙醛脱氢酶2作为蒽环类化疗药物处理肿瘤细胞时药物靶标的应用 Aldehyde dehydrogenase 2 as anthracycline chemotherapy drugs target tumor cells while processing the subject of the application
05/14/2014CN103784423A 含药口香糖的调味剂 Medicated chewing gum containing a flavoring agent
05/14/2014CN103784401A 一种治疗呼吸道疾病的溶液型定量吸入气雾剂及制备方法 A method of treating respiratory diseases was based MDIs and preparation methods
05/14/2014CN103784312A 戒烟试剂盒及其使用方法 Smoking cessation kit and method of use
05/14/2014CN102988988B 一种治疗肺曲霉病的药物组合物 A method of treating pulmonary aspergillosis pharmaceutical compositions
05/14/2014CN102824637B Trpc5作为药物靶点在逆转肿瘤多药耐药中的应用 Trpc5 as a drug target in the reversal of multidrug resistance Application
05/14/2014CN102743329B 一种宫内缓控释给药系统 One kind of controlled release drug delivery system in utero
05/14/2014CN102333543B 细胞粘附抑制剂及其用途 Cell adhesion inhibitors and their use
05/14/2014CN102159285B 作为hcv ns3蛋白酶抑制剂的大环喹喔啉化合物 As hcv ns3 protease inhibitors macrocyclic compounds quinoxaline
05/13/2014US8722866 Isoform-selective inhibitors and activators of PDE3 cyclic nucleotide phosphodiesterases
05/13/2014US8722859 Multivalent antibodies and uses therefor
05/13/2014US8722849 Polypeptides
05/13/2014US8722705 Methods for treating diffuse large B-cell lymphoma with 3-(4-amino-1-OXO-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with second active agents
05/13/2014US8722680 Method of treating neurodegenerative diseases
05/13/2014US8722647 Methods for treating amyloidosis using 4-(amino)-2-(2,6-Dioxo(3-piperidyl))- isoindoline-1,3-dione
05/13/2014US8722091 Preparation of submicron sized nanoparticles via dispersion lyophilization
05/13/2014US8722058 Bacillus strains and methods for reducing E. coli disease and enhancing performance
05/13/2014US8722055 Synthetic Streptococcus pneumoniae vaccine
05/13/2014US8722051 Tweak receptor
05/13/2014US8721963 Cold sterilization of tissue engineering scaffolds with compressed carbon dioxide
05/13/2014CA2661694C Salivary substitute
05/13/2014CA2560826C Antioxidant-promoting herbal extract compositions for alleviating oxidative stress in a mammal
05/13/2014CA2506850C Compounds and methods for increasing neurogenesis
05/13/2014CA2270345C Immunostimulatory nucleic acid molecules
05/08/2014WO2014071125A1 Combination of anti-cd20 antibody and pi3 kinase selective inhibitor
05/08/2014WO2014071122A1 Pharmaceutical compositions for the treatment of cftr mediated diseases
05/08/2014WO2014071109A1 Treatment of cancers using pi3 kinase isoform modulators
05/08/2014WO2014071105A1 Treatment of rheumatoid arthritis and asthma using p13 kinase inhibitors
05/08/2014WO2014070696A2 Medicinal treatment of chronic dermal inflammatory diseases with norketotifen
05/08/2014WO2014070523A1 Trans-clomiphene for use in cancer therapy
05/08/2014WO2014070517A1 Methods and compositions for treating progesterone-dependent conditions
05/08/2014WO2014069655A1 Immune-tolerance inducer
05/08/2014WO2014068320A1 Ketone body inhibitors for use in the treatment of gastrointestinal tract mucosa impairment
05/08/2014US20140128475 Agent for the prevention, improvement or treatment of retinal disease
05/08/2014US20140128468 Topical film-forming composition, and use thereof for treating mycoses
05/08/2014US20140128432 Anaplastic thyroid cancers harbor novel oncogenic mutations of the alk gene
05/08/2014US20140128425 Carboxy-substituted imidazo[1,2-a]pyridinecarboxamides and their use
05/08/2014US20140128424 Hydroxy-substituted imidazo[1,2-a]-pyridinecarboxamides and their use
05/08/2014US20140128420 Nutritional supplement compositions
05/08/2014US20140128408 Hdac inhibitors and therapeutic methods using the same
05/08/2014US20140128399 Methods and compositions for treating urinary tract infections using agents that mimic or elevate cyclic amp
05/08/2014US20140128387 Certain protein kinase inhibitors
05/08/2014US20140128386 Hydroxy-substituted imidazo[1,2-a]pyridinecarboxamides and their use
05/08/2014US20140128385 Bace-2 inhibitors for the treatment of metabolic disorders
05/08/2014US20140128383 Inhibitors of viral replication, their process of preparation and their therapeutical uses
05/08/2014US20140128382 5-substituted iminothiazines and their mono- and dioxides as bace inhibitors, compositions, and their use
05/08/2014US20140128377 Methods of treating refractory repetitive seizures
05/08/2014US20140128375 Benzazepine compounds as cgrp receptor antagonists
05/08/2014US20140128372 Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use
05/08/2014US20140128362 Genetic polymorphisms associated with venous thrombosis and statin response, methods of detection and uses thereof
05/08/2014US20140128355 Baclofen solution for low-volume therapeutic delivery
05/08/2014US20140128351 Combination therapy for skin disorders
05/08/2014US20140128350 Substituted Pyridine Derivatives Useful In The Treatment Of Cancer
05/08/2014US20140128339 2'-methyl substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
05/08/2014US20140128322 Compositions for Controlling Neuronal Outgrowth
05/08/2014US20140128318 Novel oxyntomodulin derivatives and pharmaceutical composition for treating obesity comprising the same
05/08/2014US20140127329 Use of nitrites for the treatment of cerebral amyloid angiopathy, age associated dementia, and cognitive decline
05/08/2014US20140127328 Methods and compositions for treating anxiety disorders or symptoms thereof
05/08/2014US20140127316 Propolis and caffeic acid phenethyl ester and uses thereof
05/08/2014US20140127296 Pharmaceutical preparation and method for treatment of diabetes
05/08/2014US20140127284 Micro-rnas and micro-rna inhibitors to modulate blood vessel growth, patterning, tumor growth and malignant disease and method for making and using them
05/08/2014US20140127280 Intrauterine delivery system for contraception
05/08/2014US20140127246 Spanx-b polypeptides and their use
05/08/2014US20140127245 Small Peptides And Methods For Treatment Of Chronic Obstructive Pulmonary Disease
05/08/2014US20140127240 Novel Binder-Drug Conjugates (ADCs) and Use of Same
05/08/2014US20140127239 Pyrrolobenzodiazepines and conjugates thereof
05/08/2014US20140127236 Humanised anti-cd52 antibodies
05/08/2014US20140127233 Pharmaceutical composition for treating ischemic events
05/08/2014US20140127217 Pharmaceutical compositions and methods to vaccinate against candidiasis
05/08/2014US20140127215 Clostridium difficile antigens
05/08/2014US20140127201 Compositions and methods related to graft versus host disease and treatments thereof
05/08/2014US20140127200 Multispecific Antibody Targeting and Multivalency Through Modular Recognition Domains
05/08/2014US20140127199 Compositions and methods for treating or preventing lupus
05/08/2014US20140127197 Anti-CD22 Antibodies and Immunoconjugates and Methods of Use
05/08/2014US20140127195 Methods of treating central nervous system ischemic or hemorrhagic injury using anti alpha4 integrin antagonists
1 ... 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 ... 1151